| NCT05114668 | Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours | COMPLETED | PHASE1 | 2021-11-03 | 2024-11-22 | 2024-11-04 |
| NCT05012670 | Mass Balance Recovery, Metabolite Profile, and Metabolite Identification of [14C]-Paxalisib in Healthy Male Subjects | COMPLETED | PHASE1 | 2021-08-18 | 2024-01-30 | 2023-03-30 |
| NCT03522298 | Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma | COMPLETED | PHASE2 | 2018-05-15 | 2023-03-30 | 2023-03-30 |
| NCT02903771 | Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. | COMPLETED | PHASE1 | 2016-12-05 | 2020-03-24 | 2020-03-24 |